LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Начало・Списък с акции・Pfizer

Pfizer

Затворен

Сектор Здравеопазване

28.56 0.32

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

28.35

Максимум

28.56

Ключови измерители
By Trading Economics
Приходи	-3.1B 41M
Продажби	-1.6B 13B
P/E Средно за сектора	15.73 103.001
EPS	0.6
Марж на печалбата	0.308
Служители	88,000
EBITDA	-3.5B 2.4B

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+14.94 upside

Дивиденти
By Dow Jones
Следващи печалби	29.10.2024 г.
Следваща дата на дивидент	2.12.2024 г.
Следваща дата на екс-дивидент	7.11.2024 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	164B
Предишно отваряне	28.24
Предишно затваряне	28.56

Настроения в новините

By Acuity

40%

60%

86 / 365 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

28.56 / 28.77 Подкрепа & съпротива

Pfizer Графика

Свързани новини

3.09.2024 г., 10:28 ч. UTC

Печалби

Pfizer, Valneva Report Positive Lyme Disease Vaccine Candidate Data

6.09.2024 г., 11:00 ч. UTC

Топ новини

Pandemic Darling Moderna Needs a Reality Check -- Heard on the Street -- WSJ

3.09.2024 г., 17:22 ч. UTC

Топ новини

Pfizer Better Watch Out for This Biotech -- Heard on the Street-- WSJ

3.09.2024 г., 10:31 ч. UTC

Пазарно говорене

Valneva Shares Gain on Positive Vaccine News -- Market Talk

23.08.2024 г., 18:38 ч. UTC

Топ новини

The U.S. Is Bringing Back Free Covid Tests This Fall -- Barrons.com

19.08.2024 г., 09:30 ч. UTC

Топ новини

Придобивния, сливания и поглъщания

Pfizer Is Staking Its Turnaround on Cancer Drugs -- WSJ

8.08.2024 г., 10:30 ч. UTC

Топ новини

Big Pharma Cuts R&D, Sending Shudders Through Industry -- Heard on the Street -- WSJ

1.08.2024 г., 15:56 ч. UTC

Печалби

Merck Created the World's Biggest Drug. Now It -2-

1.08.2024 г., 15:56 ч. UTC

Печалби

Merck Created the World's Biggest Drug. Now It Has to Replace It. -- Barrons.com

1.08.2024 г., 10:30 ч. UTC

Топ новини

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

30.07.2024 г., 17:18 ч. UTC

Печалби

Pfizer Raises Outlook Amid Strong Demand for Non-Covid Products -- WSJ

30.07.2024 г., 15:53 ч. UTC

Печалби

Nasdaq Dives As Microsoft Earnings Loom; Two Dow Jones Leaders Crater On Earnings (Live Updates) -- IBD

30.07.2024 г., 15:52 ч. UTC

Топ новини

Heard on the Street: Pfizer Finally Gets Past Covid -- WSJ

30.07.2024 г., 11:37 ч. UTC

Печалби

Pfizer Stock Rises After Guidance Hike, Earnings Beat. -- Barrons.com

30.07.2024 г., 11:18 ч. UTC

Топ новини

Печалби

Pfizer Stock Rises After Drug Maker Raises Outlook -- WSJ

30.07.2024 г., 11:12 ч. UTC

Печалби

Pfizer Stock Rises On Earnings Beat, Raised Outlook -- IBD

30.07.2024 г., 11:01 ч. UTC

Печалби

Pfizer's Stock Pops After Earnings Beat As Company Raises Guidance And Unveils Cost Cuts -- MarketWatch

30.07.2024 г., 10:50 ч. UTC

Печалби

Pfizer: Current Guidance Doesn't Anticipate Any Share Repurchases in 2024 >PFE

30.07.2024 г., 10:49 ч. UTC

Печалби

Pfizer Sees 2024 Adjusted R&D Expenses $11B-$12B >PFE

30.07.2024 г., 10:49 ч. UTC

Печалби

Pfizer Had Seen 2024 Adjusted EPS $2.15-$2.35 >PFE

30.07.2024 г., 10:48 ч. UTC

Печалби

Pfizer Now Sees 2024 Operational Rev Growth of 9%-11%; Had Seen 8%-10% >PFE

30.07.2024 г., 10:47 ч. UTC

Печалби

Pfizer Raises 2024 View To Adj EPS $2.45-Adj EPS $2.65 >PFE

30.07.2024 г., 10:47 ч. UTC

Печалби

Pfizer Raises 2024 View To Rev $59.5B-$62.5B >PFE

30.07.2024 г., 10:47 ч. UTC

Печалби

Pfizer 2Q Biopharma Revenue $12.99B, Up 2% >PFE

30.07.2024 г., 10:46 ч. UTC

Печалби

Pfizer: On Track for at Least $4B Net Cost Savings by End 2024 From Cost-Realignment Program >PFE

30.07.2024 г., 10:45 ч. UTC

Печалби

Pfizer Posts $1.3B 2Q Costs for Manufacturing Optimization Program >PFE

30.07.2024 г., 10:45 ч. UTC

Печалби

Pfizer Raises 2024 Guidance >PFE

30.07.2024 г., 10:45 ч. UTC

Печалби

Pfizer 2Q Rev $13.3B >PFE

30.07.2024 г., 10:45 ч. UTC

Печалби

Pfizer 2Q EPS 1c >PFE

30.07.2024 г., 10:45 ч. UTC

Печалби

Pfizer 2Q Adj EPS 60c >PFE

Сравнение с други в отрасъла

Ценова промяна

Pfizer Прогноза

Ценова цел

By TipRanks

14.94% нагоре

12-месечна прогноза

Среден 32.77 USD 14.94%

Висок 45 USD

Нисък 27 USD

Според 18 анализатори от Wall Street, предложили 12-месечна ценова цел за Pfizer през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

18 ratings

Купи

Задържане

Продай

Според 18 анализатори, дали борсови рейтинги на Pfizer през последните 3 месеца.

Техническа оценка

By Trading Central

28.56 / 28.77Подкрепа & съпротива

Bearish events outweigh bullish events.

Bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

Настроение

By Acuity

86 / 365 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pfizer

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. Its medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness. It sells its prescription pharmaceutical products to wholesalers, retailers, hospitals, clinics, government agencies and pharmacies. In the United States, it sells its vaccines products to the federal government, centers for disease control and prevention (CDC), wholesalers, individual provider offices, retail pharmacies and integrated delivery networks.